ATL has released a new versionof its power mode color Doppler technology for imaging blood flowin small vessels. ATL increased the performance of the technologyand renamed it Color Power Angio Imaging, the Bothell, WA, companysaid last month. Color
ATL has released a new versionof its power mode color Doppler technology for imaging blood flowin small vessels. ATL increased the performance of the technologyand renamed it Color Power Angio Imaging, the Bothell, WA, companysaid last month.
Color Power Angio Imaging supersedes Doppler Power Imagingas the marketing term for the company's power mode Doppler technology.The technique displays the amplitude of blood flow rather thanthe velocity, giving physicians a better look at weak blood flowin small vessels.
Most major ultrasound vendors have adopted different versionsof Doppler blood-vessel roadmapping and the technology has beenwell received by clinicians. Few clinical papers on the technologyhave been published, due to its novelty, however. That could changewith this year's Radiological Society of North America meeting,according to ATL president David Perozek.
"At the RSNA conference there will be a number of clinicalpapers presented, indicating and evaluating the clinical utilityof the Color Power Angio mode," Perozek said.
Also last month, ATL released a new intraoperative scanheadfor vascular surgery applications. The Entos CL10-5 transducercan help vascular surgeons identify anatomic defects that mayresult from surgery, enabling them to take corrective action whilestill in the operating room, according to the company.
Can AI Facilitate Single-Phase CT Acquisition for COPD Diagnosis and Staging?
December 12th 2024The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
Assessing MACE Risk in Women: Can an Emerging Model with SPECT MPI Imaging Have an Impact?
December 9th 2024In research involving over 2,200 women who had SPECT MPI exams, researchers found that those who had a high score with the COronary Risk Score in WOmen (CORSWO) model had a greater than fourfold higher risk of major adverse coronary events (MACE).